Press Release Description

Global Exosome Research Market to Record a Substantial CAGR of Around 15.4% During 2024-30

The Global Exosome Research Market size is anticipated to grow at a CAGR of about 15.4% during the forecast period of 2024-30, cites MarkNtel Advisors in the recent research report. The growth of the Global Exosome Research Market has been driven by several key factors, including advancements in techniques for exosome isolation and analytical procedures, along with the broadening scope of exosome applications. Moreover, the surge in both government and non-government initiatives for exosome research has further propelled market expansion. Additionally, the increasing incidence of cancer has heightened the demand for innovative diagnostic and therapeutic solutions, augmenting market growth. However, the onset of the COVID-19 pandemic disrupted research and development activities related to exosomes due to nationwide lockdowns, supply chain disruptions, and diverted investments towards COVID-19-related endeavors.

Global Exosome Research Market

Despite the challenges posed by the pandemic, it has unveiled new avenues for leveraging exosomes in the development of COVID-19 vaccines and treatments. Furthermore, the versatility of exosomes extends to diagnosing and monitoring various diseases, including neurodegenerative disorders, cancer, and cardiovascular diseases. The advantages of exosomes in drug delivery, such as their ability to penetrate biological barriers and low immunogenicity, amplify their therapeutic applications. With advancements in isolation technologies and analytical procedures, highlighted by Cell Guidance Systems' introduction of Instant Exosomes and LipoQ assay products, the utilization of exosomes in research activities is anticipated to rise, stimulating further market growth, further states the research report, “Global Exosome Research Market Analysis, 2024.”

Segmentation Analysis

Kits & Reagents Segment Holds a Major Market Share

Based on the product & service, the market is further bifurcated into kits & reagents, instruments, and services. The kits & reagents’ market share in the Global Exosome Research Market has experienced rapid expansion, driven by various factors. The demand for efficient characterization of exosomes, particularly for circulating exosomal microRNAs as biomarkers, has led to the development of user-friendly kits and reagents tailored for research purposes. Standardized exosome separation kits address the heterogeneity of exosomes and extracellular vesicles (EVs), providing researchers with a reliable method for isolating EVs from diverse biological fluids.

Moreover, advanced techniques like affinity purification and spin-column technology have enhanced exosome purification, outperforming traditional methods such as density gradient centrifugation and ultracentrifugation. Key players such as Clara Biotech, Norgen Biotech Corporation, etc. are introducing innovative kits and reagents to expand the applications of exosomes. These advancements are poised to drive further growth in the segment by empowering researchers to explore novel biomarkers and refine exosome-based therapeutics and diagnostics.

North America Dominates the Global Exosome Research Market

North America leads the exosome research industry with the largest market share, supported by its advanced healthcare infrastructure, stringent regulatory standards, and the strong presence of multinational corporations. Melanoma, lung cancer, pancreatic cancer, and other cancers are among the many cancers for which the region is committed to investigating the therapeutic potential of exosomes. This is demonstrated by the region's substantial investment in research and development, frequently conducted in partnership with esteemed academic institutions. Large-scale clinical trials, frequently supported by government funding and centered on cancer treatment, have been made possible by collaborations between prestigious universities like Yale and Michigan State and industry titans like Exosome Diagnostics and Merck.

Moreover, the adoption of state-of-the-art micro-nanotechnologies within the exosome market, particularly in immuno-oncology, is driving notable growth in the United States. With continuous advancements and the increasing uptake of such innovative technologies, North America is poised for significant expansion in the Global Exosome Research Market, offering lucrative opportunities for stakeholders across the healthcare industry.

Competitive Landscape

With strategic initiatives, such as mergers, collaborations, and acquisitions, the leading market companies, including ThermoFisher Scientific Inc., Lonza Group Ltd., Qiagen, Bio-Techne, Inc., Danaher Corporation, RoosterBio, Inc., Miltenyi Biotec, Amsbio, Norgen Biotek Corporation, Aethlon Medical Inc., Anjarium Biosciences AG, InnovaPrep LLC, Iliyas Biologics Inc., Unchained Labs, Creative Biolabs, and others are looking forward to strengthening their market positions.

Key Questions Answered in the Research Report

  1. What are the industry’s overall statistics or estimates (Overview, Market Size- By Value, Forecast Numbers, Segmentation, Market Shares)?
  2. What are the market trends influencing the current scenario of the market?
  3. What key factors would propel and impede the industry across the regions?
  4. How has the industry been evolving in terms of geography & service adoption?
  5. How has the competition been shaping up across the regions?
  6. How have the buying behavior, customer inclination, and expectations from product manufacturers been evolving during 2019-30?
  7. Who are the key competitors, and what strategic partnerships or ventures are they coming up with to stay afloat during the projected time frame?

Place an order
Only market data will be provided in the excel spreadsheet.

USD 3,700

The report will be delivered in PDF format without printing rights. It is advised for a single user.

USD 4,850

The report will be delivered in PDF format with printing rights. It is advised for up to five users.

USD 6,000

The report will be delivered in PDF format with printing rights and excel sheet. It is advised for companies where multiple users would like to access the report from multiple locations

USD 7,500

Need Assistance?

WRITE AN EMAIL

[email protected]
100% Safe & Secure

Strongest encryption on the website to make your purchase safe and secure